Head-to-head · Value Score
bmiMD vs Harper Meds
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Harper Meds a 79. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameHarper Meds
#74 · Grade B · Fair Price
Est. first month
$149/mo
Save ~89% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 79 — an est. $99/mo first month, with no teaser step-up baked in. Harper Meds isn't out of it: Shoppers who want flat-rate compounded GLP-1 with everything bundled into one price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Harper Meds |
|---|---|---|
| Value Score | 89 (A) | 79 (B) |
| Est. first month | $99/mo | $149/mo |
| Save vs brand-name | ~93% | ~89% |
| Semaglutide | $99/mo | $149/mo |
| Tirzepatide | $139/mo | $196/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Harper Meds
DTC telehealth weight-loss program (Nexus Health Solutions LLC) offering flat-rate compounded semaglutide and tirzepatide, with the consultation, prescription, medication, and shipping bundled into one…
Why it's a deal
- Flat pricing — same cost at every dose, no escalation as you titrate up
- All-inclusive: doctor consultation, prescription, medication, and free shipping in one price
- LegitScript-certified; prescriptions reviewed by US-licensed M.D.s
- Offers both compounded semaglutide ($149/mo) and tirzepatide ($196/mo)
The fine print
- Membership fee is non-refundable once paid
- Partner pharmacy is not publicly named
- State availability not published (limited to 'certain states')
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Harper Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.